Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Rang in Aktien #118
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Aktienkurs
$97.46
Zuletzt synchronisiert: 2026-10-02
Marktkapitalisierung
$168.63B
Veränderung (1 Tag)
0.77%
Veränderung (1 Jahr)
-27.59%
Land
US
Handel Abbott Laboratories (ABT)

Kategorie

Umsatz von Abbott Laboratories (ABT)
Umsatz im Jun 2026 TTM: $46.59B
Laut den aktuellen Finanzberichten von Abbott Laboratories beträgt der derzeitige Umsatz des Unternehmens (TTM) $46.59B. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $41.95B eine Steigerung gegenüber dem Umsatz im Jahr 2023, der $40.11B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Abbott Laboratories von 2000 bis 2026
Umsatz am Ende jedes Jahres
Jahr Umsatz ändert
2026 (TTM) $46.59B 5.09%
2025 $44.33B 5.67%
2024 $41.95B 4.59%
2023 $40.11B -8.12%
2022 $43.65B 1.34%
2021 $43.08B 24.47%
2020 $34.61B 8.48%
2019 $31.90B 4.34%
2018 $30.58B 11.64%
2017 $27.39B 31.35%
2016 $20.85B 2.20%
2015 $20.41B 0.78%
2014 $20.25B -7.33%
2013 $21.85B -45.21%
2012 $39.87B 2.63%
2011 $38.85B 10.48%
2010 $35.17B 14.31%
2009 $30.77B 4.19%
2008 $29.53B 13.94%
2007 $25.91B 15.30%
2006 $22.48B 0.62%
2005 $22.34B 13.51%
2004 $19.68B 0.00%
2003 $19.68B 11.29%
2002 $17.68B 8.59%
2001 $16.29B 18.47%
2000 $13.75B 0.00%
Umsatz vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Umsatz Umsatzunterschied Land
$35.48B -23.83%
IE
$25.84B -44.54%
US
$21.00B -54.93%
US
- -
DE
$6.51B -86.02%
US